Navidea Biopharmaceuticals - Recruiting 55 years or older. - Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI).
Alzheimer's Disease Cooperative Study (ADCS) - Recruiting 55 years to 85 years. - Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD).
Shanghai Mental Health Center - Recruiting 18 years or older. - The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy: A Randomized Clinical Trial And Its Standard Technology Promotion Research.
Etomidate; Propofol; Bilateral temporal MECT; The right temporal MECT; Bilateral frontal MECT
Shire Human Genetic Therapies, Inc. - Recruiting N/A to 18 years. - A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elapraser in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment.
Merck Sharp & Dohme Corp. - Recruiting 50 years to 85 years. - A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects With Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD).
Takeda - Recruiting 65 years to 83 years. - A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment Due to Alzheimer's Disease (MCI Due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD-4833 0.8 SR mg QD) to Delay the Onset of MCI Due to AD in Cognitively Normal Subjects.
Azienda Ospedaliero-Universitaria Careggi - Recruiting 18 years or older. - The Rehabilitation of Attention in Patients With Mild Cognitive Impairment and Brain Subcortical Vascular Changes Using the Attention Process Training-II.
Avid Radiopharmaceuticals - Recruiting 20 years or older. - An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease.
Charite University, Berlin, Germany - Recruiting 50 years to 80 years. - Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Patients With Mild Cognitive Impairments(MCI).
Hospital Vall d'Hebron - Recruiting 18 years to 70 years. - Clinical Trial, Randomized, Controlled, Parallel, to Evaluate the Effectiveness of Acupuncture as a Treatment in Patients Diagnosed With Chronic Fatigue Syndrome..
Parkwood Hospital, London, Ontario - Recruiting 60 years to 85 years. - Study of Community Based and Institutional Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults With Cognitive Impairment-no Dementia.
Neuronetrix, Inc. - Recruiting 60 years to 90 years. - Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISIONT) as a Useful Cognitive Biomarker for Alzheimer's Disease..
Roskilde County Hospital - Recruiting 50 years to 90 years. - Quantitative Electroencephalography, Cerebrospinal Fluid Biomarkers, Linear CT Analyses and Timed Up and GO Dual Task as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression..
Assaf-Harofeh Medical Center - Recruiting 55 years to 90 years. - The Effect of Melatonin on Memory and Other Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment (MCI): A Placebo- Controlled Study..